Rufinamide
Brand name: Rufinamide
Rank #441 of 500 drugs by total cost
$18.0M
Total Cost
8,793
Total Claims
$18.0M
Total Cost
464
Prescribers
$2,044
Cost per Claim
23
Beneficiaries
9,381
30-Day Fills
$39K
Avg Cost/Provider
19
Avg Claims/Provider
About Rufinamide
Rufinamide (sold as Rufinamide) was prescribed 8,793 times by 464 Medicare Part D providers in 2023, costing the program $18.0M. At $2,044 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 438 | Enasidenib Mesylate (Idhifa) | $18.1M | 554 |
| 439 | Posaconazole (Posaconazole) | $18.0M | 7,163 |
| 440 | Metronidazole (Metronidazole) | $18.0M | 405,967 |
| 441 | Rufinamide (Rufinamide) | $18.0M | 8,793 |
| 442 | Istradefylline (Nourianz) | $17.8M | 7,061 |
| 443 | Encorafenib (Braftovi) | $17.6M | 1,209 |
| 444 | Cladribine (Mavenclad) | $17.5M | 228 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology